References
1. Syed A, Kumari G, Kapoor A, et al. Impact of COVID-19 On Breast Cancer Management: A Radiological Prespective from A Tertiary Centre. Eur J Breast Health . 2021;17(2):180-187.
2. Ozaki A, Sawano T, Saito H, Tanimoto T, Tsubokura M. Will initial consultation patterns among undiagnosed cancer patients be the same after this COVID-19 pandemic? Experiences from the 2011 triple disaster in Fukushima, Japan. J Glob Health .2020;10(2):020343.
3. Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol.2006;24(31):5091-5097.
4. Stuart K, Brennan M, French J, Houssami N, Boyages J. Life after breast cancer. Aust Fam Physician .2006;35(4):219-224.
5. Ozaki A, Tachibana K, Ohtake T. Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to ”A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan”. Breast Cancer .2021;28(5):1163-1164.
6. Bokolo Anthony J. Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 Pandemic. J Med Syst.2020;44(7):132.
7. Fouquet SD, Miranda AT. Asking the Right Questions-Human Factors Considerations for Telemedicine Design. Curr Allergy Asthma Rep. 2020;20(11):66.
8. Chen Z, Sun S, Zhao W, et al. The Impact of the Declaration of the State of Emergency on the Spread of COVID-19: A Modeling Analysis. Comput Math Methods Med.2021;2021:8873059.
9. Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform.2010;79(11):736-771.